For the first time the CORONADX team met in person, also thanks to the PATHPOD system

The 14th and 15th of October the project partners met in Copenhagen to discuss the status of the project. A face-to-face meeting was possible thanks to PATHPOD, a diagnostic tool developed by the project.

Published on

29 Oct 2021

Category

Press releases

On October 14th and 15th, close to the mid-term of the project, the CORONADX consortium held a hybrid meeting. About half of the participants attended the meeting in person at the DTU premises.

CORONADX is one of the projects funded by the European Union’s research and innovation programme in the context of the coronavirus emergency. The project was launched on April 2020, when the world was confronting with the global pandemic and most of the European countries were under lock-down.

After one year of activities handled remotely, the CORONADX partnership has made the decision to return to face-to-face meetings. This step was made safer by the research conducted in the project.

At the beginning of the meeting, all attendees in Copenhagen were tested for COVID-19 by the PATHPOD system by DTU staff.

PATHPOD is a lab-on-a-chip system able to detect COVID-19 coronavirus in 15 minutes without the need for a laboratory. It is suitable to provide fast answers in schools, workplaces, mobile clinics or to screen travellers at transportation hubs.

After taking a swab an operator pours up to ten samples into a disposable cartridge and the device performs the analysis automatically.

The system uses the LAMP technology to amply the viral genome. Its accuracy is comparable to that of RT-PCR, the gold standard for COVID-19 testing.

Click here to find out more about the PATHPOD system.

Share this news:
Published on

29 Oct 2021

Category

Press releases

Related updates

Results

See all >

Point-of-care devices for pathogen detections: The three most important factors to realise towards commercialization

Scientific publications — 27 Aug 2020

The development of lab-on-a-chip technology and its applications in biochemical and biomedical analyses has, during the last two decades, led to the potential realisation of portable and on-site detection devices, the so-called point-of-care (PoC) detection systems. These are essentially cheap, easy-to-handle systems, offering rapid sample-to-answer results to non-technical operators. In this perspective, we do not...